Smith Jennifer S, Moses Stephen, Hudgens Michael G, Agot Kawango, Franceschi Silvia, Maclean Ian W, Ndinya-Achola J O, Parker Corette B, Pugh Norma, Meijer Chris J L M, Snijders Peter J F, Bailey Robert C
Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
Sex Transm Dis. 2007 Nov;34(11):928-34. doi: 10.1097/OLQ.0b013e318065b8ef.
Limited data are available on whether sampling from the penile shaft or urethra increases detection of penile HPV infection in men beyond that found in the glans and coronal sulcus.
Within a randomized clinical trial, a validation study of penile sampling was conducted in Kisumu, Kenya. Young men (18-24 years) were invited to provide penile exfoliated cells using prewetted Dacron swabs to determine the best site for HPV detection. beta-Globin gene PCR and HPV DNA type GP5+/6+ PCR status were ascertained from 3 anatomical sites.
A total of 98 young HIV-seronegative, uncircumcised men participated. Penile HPV prevalence varied by anatomical site: 50% in penile exfoliated cells from the glans, coronal sulcus, and inner foreskin tissue; 43% in the shaft and external foreskin tissue; and 18% in the urethra (P <0.0001). For each anatomical site, over 87% of samples were beta-globin positive. Beyond that found in the glans/coronal sulcus, urethral sampling resulted in no increase in HPV positivity and shaft sampling resulted in an additional 7.3% of overall HPV positivity. The prevalence of high-risk HPV positivity varied by anatomical site: 39% in glans/coronal sulcus, 31% in shaft, and 13% in the urethra (P <0.0001). HPV 16 was the most common type identified.
Penile HPV prevalence was approximately 50% among young men in Kisumu, Kenya. Urethral sampling for HPV detection in men added no sensitivity for HPV detection over that found from sampling the glans/coronal sulcus and penile shaft. These data will help inform studies on HPV transmission dynamics, and on the efficacy of HPV prophylactic vaccines on penile HPV carriage in men.
关于阴茎体或尿道采样是否能比龟头和冠状沟采样增加男性阴茎人乳头瘤病毒(HPV)感染的检出率,现有数据有限。
在一项随机临床试验中,于肯尼亚基苏木进行了一项阴茎采样的验证研究。邀请年轻男性(18 - 24岁)使用预先湿润的涤纶拭子提供阴茎脱落细胞,以确定HPV检测的最佳部位。从3个解剖部位确定β-珠蛋白基因PCR和HPV DNA型别GP5 + / 6 + PCR状态。
共有98名HIV血清阴性、未行包皮环切术的年轻男性参与。阴茎HPV患病率因解剖部位而异:龟头、冠状沟和包皮内板组织的阴茎脱落细胞中为50%;阴茎体和包皮外板组织中为43%;尿道中为18%(P <0.0001)。对于每个解剖部位,超过87%的样本β-珠蛋白呈阳性。除了在龟头/冠状沟发现的情况外,尿道采样并未增加HPV阳性率,而阴茎体采样使总体HPV阳性率额外增加了7.3%。高危HPV阳性率因解剖部位而异:龟头/冠状沟为39%,阴茎体为31%,尿道为13%(P <0.0001)。HPV 16是最常见的型别。
在肯尼亚基苏木的年轻男性中,阴茎HPV患病率约为50%。男性尿道采样检测HPV对HPV检测的敏感性并不高于龟头/冠状沟和阴茎体采样。这些数据将有助于为HPV传播动态以及HPV预防性疫苗对男性阴茎HPV携带的疗效研究提供信息。